Format

Send to

Choose Destination
Semin Thorac Cardiovasc Surg. 2012 Spring;24(1):8-10. doi: 10.1053/j.semtcvs.2012.04.003.

Are we ready to implant left ventricular assist devices in "less sick" patients?

Author information

1
Section of Cardiac and Thoracic Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois, USA. jeevan@uchicago.edu

Abstract

Left ventricular assist devices improve survival for New York Heart Association class IV patients as both destination therapy and bridge-to-transplant therapy. This clinical benefit has been demonstrated in multiple clinical trials whose medical comparator arm consists of patients with very poor survival. This article discusses the potential use of left ventricular assist devices in a less sick group of patients with end-stage congestive heart failure.

PMID:
22643654
DOI:
10.1053/j.semtcvs.2012.04.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center